Cargando…
Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
AIMS/HYPOTHESIS: We studied the association of plasma ascorbic acid with the risk of developing islet autoimmunity and type 1 diabetes and examined whether SNPs in vitamin C transport genes modify these associations. Furthermore, we aimed to determine whether the SNPs themselves are associated with...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946743/ https://www.ncbi.nlm.nih.gov/pubmed/31728565 http://dx.doi.org/10.1007/s00125-019-05028-z |
_version_ | 1783485426817826816 |
---|---|
author | Mattila, Markus Erlund, Iris Lee, Hye-Seung Niinistö, Sari Uusitalo, Ulla Andrén Aronsson, Carin Hummel, Sandra Parikh, Hemang Rich, Stephen S. Hagopian, William Toppari, Jorma Lernmark, Åke Ziegler, Anette G. Rewers, Marian Krischer, Jeffrey P. Norris, Jill M. Virtanen, Suvi M. |
author_facet | Mattila, Markus Erlund, Iris Lee, Hye-Seung Niinistö, Sari Uusitalo, Ulla Andrén Aronsson, Carin Hummel, Sandra Parikh, Hemang Rich, Stephen S. Hagopian, William Toppari, Jorma Lernmark, Åke Ziegler, Anette G. Rewers, Marian Krischer, Jeffrey P. Norris, Jill M. Virtanen, Suvi M. |
author_sort | Mattila, Markus |
collection | PubMed |
description | AIMS/HYPOTHESIS: We studied the association of plasma ascorbic acid with the risk of developing islet autoimmunity and type 1 diabetes and examined whether SNPs in vitamin C transport genes modify these associations. Furthermore, we aimed to determine whether the SNPs themselves are associated with the risk of islet autoimmunity or type 1 diabetes. METHODS: We used a risk set sampled nested case–control design within an ongoing international multicentre observational study: The Environmental Determinants of Diabetes in the Young (TEDDY). The TEDDY study followed children with increased genetic risk from birth to endpoints of islet autoantibodies (350 cases, 974 controls) and type 1 diabetes (102 cases, 282 controls) in six clinical centres. Control participants were matched for family history of type 1 diabetes, clinical centre and sex. Plasma ascorbic acid concentration was measured at ages 6 and 12 months and then annually up to age 6 years. SNPs in vitamin C transport genes were genotyped using the ImmunoChip custom microarray. Comparisons were adjusted for HLA genotypes and for background population stratification. RESULTS: Childhood plasma ascorbic acid (mean ± SD 10.76 ± 3.54 mg/l in controls) was inversely associated with islet autoimmunity risk (adjusted OR 0.96 [95% CI 0.92, 0.99] per +1 mg/l), particularly islet autoimmunity, starting with insulin autoantibodies (OR 0.94 [95% CI 0.88, 0.99]), but not with type 1 diabetes risk (OR 0.93 [95% Cl 0.86, 1.02]). The SLC2A2 rs5400 SNP was associated with increased risk of type 1 diabetes (OR 1.77 [95% CI 1.12, 2.80]), independent of plasma ascorbic acid (OR 0.92 [95% CI 0.84, 1.00]). CONCLUSIONS/INTERPRETATION: Higher plasma ascorbic acid levels may protect against islet autoimmunity in children genetically at risk for type 1 diabetes. Further studies are warranted to confirm these findings. DATA AVAILABILITY: The datasets generated and analysed during the current study will be made available in the NIDDK Central Repository at https://www.niddkrepository.org/studies/teddy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-05028-z) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-6946743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-69467432020-01-21 Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study Mattila, Markus Erlund, Iris Lee, Hye-Seung Niinistö, Sari Uusitalo, Ulla Andrén Aronsson, Carin Hummel, Sandra Parikh, Hemang Rich, Stephen S. Hagopian, William Toppari, Jorma Lernmark, Åke Ziegler, Anette G. Rewers, Marian Krischer, Jeffrey P. Norris, Jill M. Virtanen, Suvi M. Diabetologia Article AIMS/HYPOTHESIS: We studied the association of plasma ascorbic acid with the risk of developing islet autoimmunity and type 1 diabetes and examined whether SNPs in vitamin C transport genes modify these associations. Furthermore, we aimed to determine whether the SNPs themselves are associated with the risk of islet autoimmunity or type 1 diabetes. METHODS: We used a risk set sampled nested case–control design within an ongoing international multicentre observational study: The Environmental Determinants of Diabetes in the Young (TEDDY). The TEDDY study followed children with increased genetic risk from birth to endpoints of islet autoantibodies (350 cases, 974 controls) and type 1 diabetes (102 cases, 282 controls) in six clinical centres. Control participants were matched for family history of type 1 diabetes, clinical centre and sex. Plasma ascorbic acid concentration was measured at ages 6 and 12 months and then annually up to age 6 years. SNPs in vitamin C transport genes were genotyped using the ImmunoChip custom microarray. Comparisons were adjusted for HLA genotypes and for background population stratification. RESULTS: Childhood plasma ascorbic acid (mean ± SD 10.76 ± 3.54 mg/l in controls) was inversely associated with islet autoimmunity risk (adjusted OR 0.96 [95% CI 0.92, 0.99] per +1 mg/l), particularly islet autoimmunity, starting with insulin autoantibodies (OR 0.94 [95% CI 0.88, 0.99]), but not with type 1 diabetes risk (OR 0.93 [95% Cl 0.86, 1.02]). The SLC2A2 rs5400 SNP was associated with increased risk of type 1 diabetes (OR 1.77 [95% CI 1.12, 2.80]), independent of plasma ascorbic acid (OR 0.92 [95% CI 0.84, 1.00]). CONCLUSIONS/INTERPRETATION: Higher plasma ascorbic acid levels may protect against islet autoimmunity in children genetically at risk for type 1 diabetes. Further studies are warranted to confirm these findings. DATA AVAILABILITY: The datasets generated and analysed during the current study will be made available in the NIDDK Central Repository at https://www.niddkrepository.org/studies/teddy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-05028-z) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2019-11-14 2020 /pmc/articles/PMC6946743/ /pubmed/31728565 http://dx.doi.org/10.1007/s00125-019-05028-z Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Mattila, Markus Erlund, Iris Lee, Hye-Seung Niinistö, Sari Uusitalo, Ulla Andrén Aronsson, Carin Hummel, Sandra Parikh, Hemang Rich, Stephen S. Hagopian, William Toppari, Jorma Lernmark, Åke Ziegler, Anette G. Rewers, Marian Krischer, Jeffrey P. Norris, Jill M. Virtanen, Suvi M. Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study |
title | Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study |
title_full | Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study |
title_fullStr | Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study |
title_full_unstemmed | Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study |
title_short | Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study |
title_sort | plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the teddy study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946743/ https://www.ncbi.nlm.nih.gov/pubmed/31728565 http://dx.doi.org/10.1007/s00125-019-05028-z |
work_keys_str_mv | AT mattilamarkus plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT erlundiris plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT leehyeseung plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT niinistosari plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT uusitaloulla plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT andrenaronssoncarin plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT hummelsandra plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT parikhhemang plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT richstephens plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT hagopianwilliam plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT topparijorma plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT lernmarkake plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT ziegleranetteg plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT rewersmarian plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT krischerjeffreyp plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT norrisjillm plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT virtanensuvim plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy AT plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy |